Literature DB >> 1657900

Bifunctional atrial natriuretic peptide receptor (type A) exists as a disulfide-linked tetramer in plasma membranes of bovine adrenal cortex.

T Iwata1, K Uchida-Mizuno, T Katafuchi, T Ito, H Hagiwara, S Hirose.   

Abstract

Type A atrial natriuretic peptide (ANP) receptor was demonstrated to be present as a tetramer in the bovine adrenal cortex. Type A ANP receptor is composed of two functional domains, namely extracellular ANP-binding and cytoplasmic guanylate cyclase domains, and generally considered to be present as a single polypeptide chain of about 140 kDa based on its primary structure deduced from the cDNA sequence and its SDS/PAGE profile under reducing conditions. Characterization of the type A receptor or receptor/cyclase under non-reducing conditions led to the discovery stated in the title. The type A ANP receptor was partially purified from bovine adrenal cortex membranes by Blue-Sepharose and GTP-agarose chromatography. SDS-PAGE analysis of the receptor preparation revealed that although under reducing conditions it migrated as a 140-kDa band, the mobility of the receptor was greatly retarded in the absence of reducing agents, suggesting that the type A ANP receptor is present as a disulfide-linked oligomer in its native state. Further analysis using SDS-polyacrylamide-agarose gels suitable for determining the sizes of high-molecular-weight proteins revealed that the oligomer has an Mr of 500,000-550,000. This result clearly indicates that the native form of the type A receptor is a tetramer composed of four 140-kDa disulfide-linked receptor/cyclase molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657900     DOI: 10.1093/oxfordjournals.jbchem.a123539

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  A mutation of the atrial natriuretic peptide (guanylyl cyclase-A) receptor results in a constitutively hyperactive enzyme.

Authors:  B J Wedel; D C Foster; D E Miller; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Comparative binding study of rat natriuretic peptide receptor-A.

Authors:  M Marquis; R Fenrick; L Pedro; M Bouvier; A De Léan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 3.  Guanylyl cyclase receptors.

Authors:  D L Garbers; D Koesling; G Schultz
Journal:  Mol Biol Cell       Date:  1994-01       Impact factor: 4.138

4.  Structural analysis of natriuretic peptide receptor-C by truncation and site-directed mutagenesis.

Authors:  M Itakura; H Suzuki; S Hirose
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 5.  Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.

Authors:  Johanne Tremblay; Richard Desjardins; David Hum; Jolanta Gutkowska; Pavel Hamet
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor.

Authors:  L R Potter; T Hunter
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

Review 7.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Natriuretic peptide receptor mRNAs in the rat and human heart.

Authors:  D J Nunez; M C Dickson; M J Brown
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Mutations in Tyr808 reveal a potential auto-inhibitory mechanism of guanylate cyclase-B regulation.

Authors:  Takeshi Katafuchi
Journal:  Biosci Rep       Date:  2013-05-24       Impact factor: 3.840

10.  Hormonal induction of low affinity receptor guanylyl cyclase.

Authors:  J R Jewett; K J Koller; D V Goeddel; D G Lowe
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.